NCT05420727View on ClinicalTrials.gov

Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

April 9, 2024

Study Completion Date

April 30, 2024

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Ga-68-PSMA-11 PET/CT

Ga-68-PSMA-11 PET/CT imaging

DRUG

Lu-177-ITG-PSMA-1

Lu-177-ITG-PSMA-1 treatment

Trial Locations (1)

1011

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors
lead

John O. Prior

OTHER